|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Ophthalmic_division_of_Merck_&_Co.
gptkb:Santen_Pharmaceutical_Co.,_Ltd.
gptkb:InnFocus,_Inc.
|
|
gptkbp:awards
|
Best Companies to Work For
Ophthalmology Product of the Year
Pharma Innovation Award
|
|
gptkbp:CEO
|
gptkb:Akihiro_Kurokawa
|
|
gptkbp:community_involvement
|
health education programs
volunteer initiatives
charitable donations
partnerships with NGOs
sustainability projects
|
|
gptkbp:employees
|
over 1,500
|
|
gptkbp:focus
|
research and development
sustainability
patient care
market expansion
product innovation
|
|
gptkbp:founded
|
1890
|
|
gptkbp:hasPart
|
gptkb:Santen_UK_Ltd.
gptkb:Santen_GmbH
gptkb:Santen_Inc.
gptkb:Santen_Pharmaceutical_Co.,_Ltd.
gptkb:Santen_France
|
|
gptkbp:headquarters
|
gptkb:Osaka,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Santen SA
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:operatesIn
|
gptkb:Asia
gptkb:Japan
Europe
|
|
gptkbp:partnerships
|
gptkb:EyePoint_Pharmaceuticals
gptkb:Aerie_Pharmaceuticals
gptkb:Bausch_+_Lomb
gptkb:Ocular_Therapeutix
Novartis
|
|
gptkbp:research
|
clinical trials
medical devices
biologics
digital health solutions
new drug development
|
|
gptkbp:revenue
|
$1 billion (2020)
|
|
gptkbp:specializesIn
|
ophthalmology
|
|
gptkbp:subsidiary
|
gptkb:Santen_UK_Ltd.
gptkb:Santen_GmbH
gptkb:Santen_Inc.
gptkb:Santen_France
|
|
gptkbp:website
|
www.santen.com
|